BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 15670774)

  • 21. Adenomatous polyposis coli protein (APC)-independent regulation of beta-catenin/Tcf-4 mediated transcription in intestinal cells.
    Baulida J; Batlle E; García De Herreros A
    Biochem J; 1999 Dec; 344 Pt 2(Pt 2):565-70. PubMed ID: 10567241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers.
    Takahashi M; Tsunoda T; Seiki M; Nakamura Y; Furukawa Y
    Oncogene; 2002 Aug; 21(38):5861-7. PubMed ID: 12185585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The beta-catenin binding domain of adenomatous polyposis coli is sufficient for tumor suppression.
    Shih IM; Yu J; He TC; Vogelstein B; Kinzler KW
    Cancer Res; 2000 Mar; 60(6):1671-6. PubMed ID: 10749138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB.
    Cho M; Gwak J; Park S; Won J; Kim DE; Yea SS; Cha IJ; Kim TK; Shin JG; Oh S
    FEBS Lett; 2005 Aug; 579(20):4213-8. PubMed ID: 16051228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas.
    Fujita M; Furukawa Y; Tsunoda T; Tanaka T; Ogawa M; Nakamura Y
    Cancer Res; 2001 Nov; 61(21):7722-6. PubMed ID: 11691783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide-donating aspirin inhibits beta-catenin/T cell factor (TCF) signaling in SW480 colon cancer cells by disrupting the nuclear beta-catenin-TCF association.
    Nath N; Kashfi K; Chen J; Rigas B
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12584-9. PubMed ID: 14566053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of beta-catenin aggregation and localization using GFP fusion proteins: nuclear import of alpha-catenin by the beta-catenin/Tcf complex.
    Giannini AL; Vivanco MM; Kypta RM
    Exp Cell Res; 2000 Mar; 255(2):207-20. PubMed ID: 10694436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mammalian two-hybrid system for adenomatous polyposis coli-mutated colon cancer therapeutics.
    Wakita K; Tetsu O; McCormick F
    Cancer Res; 2001 Feb; 61(3):854-8. PubMed ID: 11221869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An RNA aptamer that binds to the beta-catenin interaction domain of TCF-1 protein.
    Lee SK; Park MW; Yang EG; Yu J; Jeong S
    Biochem Biophys Res Commun; 2005 Feb; 327(1):294-9. PubMed ID: 15629461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
    Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
    Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic expression of Lef/Tcf family members and beta-catenin during chick gastrulation, neurulation, and early limb development.
    Schmidt M; Patterson M; Farrell E; Münsterberg A
    Dev Dyn; 2004 Mar; 229(3):703-7. PubMed ID: 14991726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
    Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
    EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galectin-3, a novel binding partner of beta-catenin.
    Shimura T; Takenaka Y; Tsutsumi S; Hogan V; Kikuchi A; Raz A
    Cancer Res; 2004 Sep; 64(18):6363-7. PubMed ID: 15374939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
    Jung HC; Kim K
    Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC; Ronchini C; Capobianco AJ
    Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW; Roh H; Pippin JA; Drebin JA
    J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effect of nordihydroguaiaretic acid on β-catenin/Tcf signalling in β-catenin-activated cells.
    Park S; Lee J
    Cell Biochem Funct; 2011; 29(1):22-9. PubMed ID: 21264886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of beta-catenin-mediated transactivation by flavanone in AGS gastric cancer cells.
    Park CH; Hahm ER; Lee JH; Jung KC; Yang CH
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1222-8. PubMed ID: 15883006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.